Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling

Ken-Ichi Takayama1,2

  • 1Department of Functional Biogerontology, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan. ktakayama-tky@umin.ac.jp.

Biomolecules
|April 4, 2019
PubMed

Insights

Splicing factors are key drivers in prostate cancer progression, promoting androgen receptor (AR) expression and variants like AR-V7. Targeting these splicing factors offers a promising therapeutic strategy for castration-resistant prostate cancer (CRPC).

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer growth is initially controlled by the androgen-androgen receptor (AR) axis.
  • Most prostate cancers eventually develop resistance to castration, becoming castration-resistant prostate cancers (CRPCs).
  • Increased AR expression and its variants, such as AR-V7, are crucial for CRPC progression.

Purpose of the Study:

  • To explore the molecular mechanisms behind increased AR expression and AR-V7 generation in CRPC.
  • To highlight the role of RNA splicing factors in prostate cancer progression and AR signaling.
  • To identify splicing factors as potential therapeutic targets for CRPC.

Main Methods:

  • Review of recent literature on RNA splicing factors and their impact on AR signaling.
  • Analysis of aberrant regulation of splicing components in CRPC tissues.
  • Investigation of the role of RNA-binding protein splicing factor proline- and glutamine-rich (PSF/SFPQ) in AR variant production.
  • Evaluation of in vivo tumor growth inhibition by targeting splicing factors.
  • Correlation analysis between splicing factor expression and biochemical recurrence in prostate cancer patients.

Main Results:

  • RNA splicing factors significantly influence AR expression and the production of AR variants like AR-V7.
  • Aberrant regulation of splicing components is observed in CRPC tissues.
  • The splicing factor PSF/SFPQ enhances spliceosome gene expression, altering AR transcript variants.
  • Inhibition of specific splicing factors demonstrated tumor growth repression in vivo.
  • Altered splicing factor expression correlates with biochemical recurrence in prostate cancer patients.

Conclusions:

  • Splicing factors play a critical role in the progression of prostate cancer, particularly in the development of CRPC.
  • Targeting aberrant RNA splicing represents a novel and promising therapeutic strategy for prostate cancer.
  • Splicing factors are potential therapeutic targets for managing advanced prostate cancer and overcoming castration resistance.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.5K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.4K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.8K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.4K
Signal Sequences and Sorting Receptors01:41

Signal Sequences and Sorting Receptors

Signal sequences are short amino acid sequences that guide newly synthesized proteins to their proper location within the cell. Classical signal sequences are fifteen to sixty amino acids long and present at the N-terminus of a polypeptide chain. Each signal sequence has a conserved segment of basic residues towards their N terminus, a hydrophobic core, and a C-terminus rich in polar residues. The C-terminus also contains a signal cleavage site and features a -3 -1 sequence motif. The -3-1...
14.9K